A brief return of symptoms may be part of the natural history of SARS-CoV-2 infection in some persons, independent of treatment with nirmatrelvir/ritonavir (Paxlovid) and regardless of vaccination status, according to this CDC advisory on reports of COVID-19 rebound cases.